| Features: |
| Vitamin K2 (menaquinone) Menaquinone-4 (MK-4), a subtype of vitamin K2 Helps blood clot, calcium metabolise and heart health. Bone health: Vitamin K2 helps to regulate calcium levels in the body, which can help to prevent conditions such as osteoporosis and fractures. Vitamin K2 has been studied for its potential role in cancer prevention and treatment. Some of the key findings include: -Shown to inhibit the growth of cancer cells, including those found in leukemia, lung cancer, and prostate cancer. -Shown to induce apoptosis (cell death) in cancer cells, which can help to prevent the spread of cancer. -Shown to have anti-angiogenic effects, which means it can help to prevent the formation of new blood vessels that feed cancer cells. -Synergistic effects with other nutrients, such as vitamin D and calcium, to enhance its anti-cancer effects. UBIAD1 is the enzyme that makes MK-4 inside tissues Vitamin K2 exists in several forms known as menaquinones, with MK-4 and MK-7 being the most studied. MK-4 is often used in Japan for therapeutic purposes, whereas MK-7 (derived from bacterial fermentation) is widely available as a supplement in Western countries. For bone and cardiovascular health—and by extension, exploring potential anticancer benefits—doses for MK-7 commonly range from 90 to 200 micrograms per day. |
| Source: |
| Type: |
| LDHA is a key enzyme that catalyzes the conversion of pyruvate into lactate while regenerating NAD+, essential for glycolysis. Elevated levels of LDHA have been associated with increased tumor growth and survival. By promoting lactate production, cancer cells can create an acidic microenvironment that may facilitate invasion and metastasis. Is often upregulated in various types of cancer, including breast, lung, colorectal, and prostate cancers. This upregulation is associated with the metabolic shift that cancer cells undergo to support rapid growth and proliferation. Measuring the lactate dehydrogenase (LDH) is a useful method for detection of necrosis. |
| 1214- | VitK2, | Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells |
| - | in-vitro, | Bladder, | T24/HTB-9 | - | in-vitro, | Bladder, | J82 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:168 Target#:175 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid